Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-25T00:15:59.198Z.
Calculation as of: 2026-09-25T00:15:59.198Z.
Quote observation: 2026-09-24T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d36a9ef3dd00a3b0176393925906ed0ad09061a29621a98fe511a29c7f47a262
PEG RATIO
N/A
ResMed Inc.
Market Cap
$32.19B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| ResMed Inc. (RMD) | $32.19B | N/A |
| Alcon Inc. (ALC)vs › | $31.49B | N/A |
| DexCom, Inc. (DXCM)vs › | $33.01B | N/A |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $33.40B | N/A |
| Biogen Inc. (BIIB)vs › | $33.45B | N/A |
| Mettler-Toledo International Inc. (MTD)vs › | $30.70B | N/A |
| Centene Corp. (CNC)vs › | $30.58B | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.98B | N/A |
| Zoetis Inc. (ZTS)vs › | $29.48B | N/A |
| Medline Inc. (MDLN)vs › | $29.31B | N/A |
PEG Ratio
N/A
P/E Ratio
21.3
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
